Medical Decision Making

1981 - 2025

Bibliographic data for series maintained by SAGE Publications ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 29, issue 6, 2009

Comparative Effectiveness Research pp. 641-641

Mark Helfand

CER Essay Introduction pp. 642-642

Kathryn M. McDonald

Dimensions of Design Space: A Decision-Theoretic Approach to Optimal Research Design pp. 643-660

Stefano Conti and Karl Claxton

The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies pp. 661-677

Peter C. Austin

The Cost-Effectiveness of an RCT to Establish Whether 5 or 10 Years of Bisphosphonate Treatment Is the Better Duration for Women With a Prior Fracture pp. 678-689

Matt D. Stevenson, Jeremy E. Oakley, Myfawny Lloyd Jones, Alan Brennan, Juliet E. Compston, Eugene V. McCloskey and Peter L. Selby

Evaluating the Claim of Enhanced Persistence: The Case of Osteoporosis and Implications for Payers pp. 690-706

Christina M. L. Kelton and Margaret K. Pasquale

Does One Size Fit All? Investigating Heterogeneity in Men’s Preferences for Benign Prostatic Hyperplasia Treatment Using Mixed Logit Analysis pp. 707-715

Barbara Eberth, Verity Watson, Mandy Ryan, Jenny Hughes and Gillian Barnett

On Transparency in Decision Analytic Models pp. NP1-NP2

Nancy Neil

Comparative Effectiveness Research and Cancer Screening in the United States and Europe pp. NP12-NP13

David H. Howard

Are We Equipped to Train the Future Comparative Effectiveness Research Workforce? pp. NP14-NP15

Daniel Jonas and Karen Crotty

Comparative Effectiveness: A Table of Expected Benefits and Harms pp. NP3-NP5

Michael W. Kattan

Comparative Effectiveness Research Through the Looking Glass pp. NP6-NP8

Adrian Levy, Brian Harrigan, Karissa Johnston and Andrew Briggs

Individualization at the Heart of Comparative Effectiveness Research: The Time for i-CER Has Come pp. NP9-NP11

Anirban Basu

Volume 29, issue 5, 2009

Using the Principles of Randomized Controlled Trial Design to Guide Test Evaluation pp. E1-E12

Sarah J. Lord, Les Irwig and Patrick M. M. Bossuyt

Proposals for a Phased Evaluation of Medical Tests pp. E13-E21

Jeroen G. Lijmer, Mariska Leeflang and Patrick M. M. Bossuyt

Decision-Analytic Modeling to Evaluate Benefits and Harms of Medical Tests: Uses and Limitations pp. E22-E29

Thomas A. Trikalinos, Uwe Siebert and Joseph Lau

Additional Patient Outcomes and Pathways in Evaluations of Testing pp. E30-E38

Patrick M. M. Bossuyt and Kirsten McCaffery

Effects of Categorizing Continuous Variables in Decision-Analytic Models pp. 549-556

Tanya G. K. Bentley, Milton C. Weinstein and Karen M. Kuntz

Incorporating Herd Immunity Effects into Cohort Models of Vaccine Cost-Effectiveness pp. 557-569

Chris T. Bauch, Andrea M. Anonychuk, Thierry Van Effelterre, Ba' Z. Pham and Maraki Fikre Merid

Planning Posttherapeutic Oncology Surveillance Visits Based on Individual Risk pp. 570-579

T. Filleron, A. Barrett, O. Ataman and A. Kramar

Incorporating Extrinsic Goals Into Decision and Cost-Effectiveness Analyses pp. 580-589

Gordon B. Hazen and Alan Schwartz

Development of Goal-Sensitive Health-Related Utility Assessment Procedures pp. 590-598

Alan Schwartz, Gordon B. Hazen, Ariel Leifer and Paul S. Heckerling

The Influence of Treatment Effect Size on Willingness to Adopt a Therapy pp. 599-605

Scott K. Aberegg, James M. O'Brien, Paneez Khoury, Roocha Patel and Hal Arkes

Diagnostic Certainty as a Source of Medical Practice Variation in Coronary Heart Disease: Results from a Cross-National Experiment of Clinical Decision Making pp. 606-618

Karen E. Lutfey, Carol L. Link, Lisa D. Marceau, Richard W. Grant, Ann Adams, Sara Arber, Johannes Siegrist, Markus Bönte, Olaf von dem Knesebeck and John B. McKinlay

The German Coronary Artery Disease Risk Screening Model: Development, Validation, and Application of a Decision-Analytic Model for Coronary Artery Disease Prevention with Statins pp. 619-633

Björn Stollenwerk, Andreas Gerber, Karl W. Lauterbach and Uwe Siebert

Web Exclusive White Paper Series on Diagnostic Test Evaluation pp. 634-635

Mark Helfand

Volume 29, issue 4, 2009

Getting Down to Details in the Design and Use of Decision Aids pp. 409-411

Angela Fagerlin

Modeling Bioterrorism and Disaster Preparedness: SMDM's Recommendations for Design and Reporting pp. 412-413

Gillian D. Sanders

Evaluating the Capability and Cost of a Mass Influenza and Pneumococcal Vaccination Clinic via Computer Simulation pp. 414-423

Michael L. Washington

Predicting Hospital Surge after a Large-Scale Anthrax Attack: A Model-Based Analysis of CDC's Cities Readiness Initiative Prophylaxis Recommendations pp. 424-437

Nathaniel Hupert, Daniel Wattson, Jason Cuomo, Eric Hollingsworth, Kristof Neukermans and Wei Xiong

Recommendations for Modeling Disaster Responses in Public Health and Medicine: A Position Paper of the Society for Medical Decision Making pp. 438-460

Margaret L. Brandeau, Jessica H. McCoy, Nathaniel Hupert, Jon-Erik Holty and Dena M. Bravata

Long-Term Health Outcomes of a Decision Aid: Data from a Randomized Trial of Adjuvant! in Women with Localized Breast Cancer pp. 461-467

Andrew J. Vickers, Elena B. Elkin, Pamela B. Peele, Maura Dickler and Laura A. Siminoff

Should Clinicians Deliver Decision Aids? Further Exploration of the Statin Choice Randomized Trial Results pp. 468-474

Lesley A. Jones, Audrey J. Weymiller, Nilay Shah, Sandra C. Bryant, Teresa J. H. Christianson, Gordon H. Guyatt, Amiram Gafni, Steven A. Smith and Victor M. Montori

Is There a Role for Decision Aids in Advanced Breast Cancer? pp. 475-482

Karen R. Sepucha, Elissa M. Ozanne, Ann H. Partridge and Beverly Moy

Effect of Risk Communication Formats on Risk Perception Depending on Numeracy pp. 483-490

Carmen Keller and Michael Siegrist

A Fair Test of the Fair Innings? pp. 491-499

Adam Oliver

The Half-Cycle Correction: Banish Rather Than Explain It pp. 500-502

Jan J. Barendregt

The Incorporation of Income and Leisure in Health State Valuations When the Measure Is Silent: An Empirical Inquiry into the Sound of Silence pp. 503-512

Werner Brouwer, Saskia Grootenboer and Pedram Sendi

Construction of Health Preferences: A Comparison of Direct Value Assessment and Personal Narratives pp. 513-520

José H. Kerstholt, Fred van der Zwaard, Hans Bart and Anita Cremers

Offering Chemotherapy and Hospice Jointly: One Solution to Hospice Underuse pp. 521-531

Talya Salz and Noel T. Brewer

Quantitative Risk Stratification in Markov Chains with Limiting Conditional Distributions pp. 532-540

David C. Chan, Philip K. Pollett and Milton C. Weinstein

Errata pp. 541-541

N/a

Volume 29, issue 3, 2009

How Far Do You Go? Efficient Searching for Indirect Evidence pp. 273-281

Neil Hawkins, David A. Scott and Beth Woods

Missing Celiac Disease in Family Medicine: The Importance of Hypothesis Generation pp. 282-290

Olga Kostopoulou, Charlotte Devereaux-Walsh and Brendan C. Delaney

Estimating Preference-Based Health Utilities Index Mark 3 Utility Scores for Childhood Conditions in England and Scotland pp. 291-303

Stavros Petrou and Emil Kupek

A Hybrid Cohort Individual Sampling Natural History Model of Age-Related Macular Degeneration: Assessing the Cost-Effectiveness of Screening Using Probabilistic Calibration pp. 304-316

Jonathan Karnon, Carolyn Czoski-Murray, Kevin J. Smith and Christopher Brand

Physicians' Anticipated Regret and Diagnostic Testing: Comment on Hozo and Djulbegovic, 2008 pp. 317-319

Michael L. DeKay

Will Insistence on Practicing Medicine According to Expected Utility Theory Lead to an Increase in Diagnostic Testing? Reply to DeKay's Commentary: Physicians' Anticipated Regret and Diagnostic Testing pp. 320-324

Iztok Hozo and Benjamin Djulbegovic

Long-Term Cost-Effectiveness of Disease Management in Systolic Heart Failure pp. 325-333

George Miller, Stephen Randolph, Emma Forkner, Brad Smith and Autumn Dawn Galbreath

Valuing Health: Does Enriching a Scenario Lead to Higher Utilities? pp. 334-342

Yvette Peeters and Anne M. Stiggelbout

Early Stopping Rules in Clinical Trials Based on Sequential Monitoring of Serious Adverse Events pp. 343-350

A. Kramar and C. Bascoul-Mollevi

Optimizing the Start Time of Statin Therapy for Patients with Diabetes pp. 351-367

Brian T. Denton, Murat Kurt, Nilay D. Shah, Sandra C. Bryant and Steven A. Smith

Natural Frequencies Help Older Adults and People with Low Numeracy to Evaluate Medical Screening Tests pp. 368-371

Mirta Galesic, Gerd Gigerenzer and Nils Straubinger

The Effect of Erroneous Computer Interpretation of ECGs on Resident Decision Making pp. 372-376

William N. Southern and Julia Hope Arnsten

The Hippocratic Oath, Effect Size, and Utility Theory pp. 377-379

Robert F. Bordley

Weighing Harm in Therapeutic Decisions of Smear-Negative Pulmonary Tuberculosis pp. 380-390

Juan Moreira, Bettina Bisig, Petronille Muwawenimana, Paulin Basinga, Zeno Bisoffi, Frank Haegeman, Panduru Kishore and Jef Van den Ende

Laypersons' Responses to the Communication of Uncertainty Regarding Cancer Risk Estimates pp. 391-403

Paul K. J. Han, William M. P. Klein, Thomas C. Lehman, Holly Massett, Simon C. Lee and Andrew N. Freedman

Volume 29, issue 2, 2009

Health Literacy and Cancer Risk Perception: Implications for Genomic Risk Communication pp. 157-166

Noel T. Brewer, Janice P. Tzeng, Sarah E. Lillie, Alrick S. Edwards, Jeffrey M. Peppercorn and Barbara K. Rimer

Randomized Trial of Presenting Absolute v. Relative Risk Reduction in the Elicitation of Patient Values for Heart Disease Prevention With Conjoint Analysis pp. 167-174

Jennifer M. Griffith, Carmen L. Lewis, Sarah Hawley, Stacey L. Sheridan and Michael P. Pignone

The Psychosocial Effect of Thoughts of Personal Mortality on Cardiac Risk Assessment pp. 175-181

Jamie Arndt, Matthew Vess, Cathy R. Cox, Jamie L. Goldenberg and Stephen Lagle

Intertemporal Tradeoffs: Perceiving the Risk in the Benefits of Marijuana in a Prospective Study of Adolescents and Young Adults pp. 182-192

Julie H. Goldberg, Susan Millstein, Alan Schwartz and Bonnie Halpern-Felsher

Anchoring-and-Adjustment Bias in Communication of Disease Risk pp. 193-201

Ibrahim Senay and Kimberly A. Kaphingst

Computer and Internet Use in a Community Health Clinic Population pp. 202-206

Neeraja B. Peterson, Kathleen A. Dwyer and Shelagh A. Mulvaney

Value for Money in Changing Clinical Practice: Should Decisions about Guidelines and Implementation Strategies Be Made Sequentially or Simultaneously? pp. 207-216

Ties Hoomans, Johan L. Severens, Silvia M. A. A. Evers and Andre J. H. A. Ament

Competence of General Practitioners in Giving Advice about Changes in Lifestyle to Hypertensive Patients pp. 217-223

Adam Windak, Barbara Gryglewska, Tomasz Tomasik, Krzysztof Narkiewicz and Tomasz Grodzicki

The Cost-Effectiveness of Screening for Hereditary Hemochromatosis in Germany: A Remodeling Study pp. 224-238

Wolf H. Rogowski

Development of a Clinical Prediction Model to Calculate Patient Life Expectancy: The Measure of Actuarial Life Expectancy (MALE) pp. 239-246

M.G. Clarke, K.P. Kennedy and R.P. MacDonagh

Validation of an Automated Safety Surveillance System with Prospective, Randomized Trial Data pp. 247-256

Michael E. Matheny, David A. Morrow, Lucila Ohno-Machado, Christopher P. Cannon, Marc S. Sabatine and Frederic S. Resnic

Impact of the Scale Upper Anchor on Health State Preferences pp. 257-266

Joseph T. King, Joel Tsevat and Mark S. Roberts

Volume 29, issue 1, 2009

30th Annual Meeting of the Society for Medical Decision Making Abstracts pp. E1-E98

N/a

Author Index for Abstracts pp. 1-5

N/a

Thank You to Our Reviewers pp. 5-6

N/a

A Randomized Study of Scleroderma Health State Values: A Picture Is Worth a Thousand Words, and Quite a Few Utilities pp. 7-14

Dinesh Khanna, Robert M. Kaplan, Mark H. Eckman, Ron D. Hays, Anthony C. Leonard, Shaari S. Ginsburg and Joel Tsevat

What Would It Be Like for Me and for You? Judged Impact of Chronic Health Conditions on Happiness pp. 15-22

Emma Walsh and Peter Ayton

Labor Market Productivity Costs for Caregivers of Children with Spina Bifida: A Population-Based Analysis pp. 23-32

John M. Tilford, Scott D. Grosse, Allen C. Goodman and Kemeng Li

Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver(s) and ``No Medical Care'' Disease Impact in Belgium pp. 33-50

Joke Bilcke, Pierre Van Damme and Philippe Beutels

Cost-Effectiveness of Insuring the Uninsured: The Case of Korean American Children pp. 51-60

Judy Y. Chen, Sharon Swonger, Gerald Kominski, Honghu Liu, Ji Eun Lee and Allison Diamant

Decisional Conflict in Patients and Their Physicians: A Dyadic Approach to Shared Decision Making pp. 61-68

Annie LeBlanc, David A. Kenny, Annette M. O'Connor and France Légaré

Modifying ICD-9-CM Coding of Secondary Diagnoses to Improve Risk-Adjustment of Inpatient Mortality Rates pp. 69-81

Michael Pine, Harmon S. Jordan, Anne Elixhauser, Donald E. Fry, David C. Hoaglin, Barbara Jones, Roger Meimban, David Warner and Junius Gonzales

Do Intraindividual Variation in Disease Progression and the Ensuing Tight Window of Opportunity Affect Estimation of Screening Benefits? pp. 82-90

Hendrik Koffijberg, Gabriel Rinkel and Erik Buskens

Controlling for Drug Dose in Systematic Review and Meta-Analysis: A Case Study of the Effect of Antidepressant Dose pp. 91-103

Richard A. Hansen, Charity G. Moore, Stacie B. Dusetzina, Brian I. Leinwand, Gerald Gartlehner and Bradley N. Gaynes

A Multiattribute Model for Evaluating the Benefit-Risk Profiles of Treatment Alternatives pp. 104-115

James C. Felli, Rebecca A. Noel and Patrizia A. Cavazzoni

Incorporating Uncertainty Into Medical Decision Making: An Approach to Unexpected Test Results pp. 116-124

Matt T. Bianchi, Brian M. Alexander and Sydney S. Cash

A Markov Model Simulation of the Impact of Treatment Persistence in Postmenopausal Osteoporosis pp. 125-139

François-Emery Cotté, Bruno Fautrel and Gérard De Pouvourville

Improving Fast and Frugal Modeling in Relation to Regression Analysis: Test of 3 Models for Medical Decision Making pp. 140-148

Lars G. Backlund, Johan Bring, Ylva Skånér, Lars-Erik Strender and Henry Montgomery